Cargando…
Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization
BACKGROUND: Drug-drug interactions (DDIs) always cause unexpected and even adverse drug reactions. It is important to identify DDIs before drugs are used in the market. However, preclinical identification of DDIs requires much money and time. Computational approaches have exhibited their abilities t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907306/ https://www.ncbi.nlm.nih.gov/pubmed/29671393 http://dx.doi.org/10.1186/s12918-018-0532-7 |
_version_ | 1783315504495067136 |
---|---|
author | Yu, Hui Mao, Kui-Tao Shi, Jian-Yu Huang, Hua Chen, Zhi Dong, Kai Yiu, Siu-Ming |
author_facet | Yu, Hui Mao, Kui-Tao Shi, Jian-Yu Huang, Hua Chen, Zhi Dong, Kai Yiu, Siu-Ming |
author_sort | Yu, Hui |
collection | PubMed |
description | BACKGROUND: Drug-drug interactions (DDIs) always cause unexpected and even adverse drug reactions. It is important to identify DDIs before drugs are used in the market. However, preclinical identification of DDIs requires much money and time. Computational approaches have exhibited their abilities to predict potential DDIs on a large scale by utilizing pre-market drug properties (e.g. chemical structure). Nevertheless, none of them can predict two comprehensive types of DDIs, including enhancive and degressive DDIs, which increases and decreases the behaviors of the interacting drugs respectively. There is a lack of systematic analysis on the structural relationship among known DDIs. Revealing such a relationship is very important, because it is able to help understand how DDIs occur. Both the prediction of comprehensive DDIs and the discovery of structural relationship among them play an important guidance when making a co-prescription. RESULTS: In this work, treating a set of comprehensive DDIs as a signed network, we design a novel model (DDINMF) for the prediction of enhancive and degressive DDIs based on semi-nonnegative matrix factorization. Inspiringly, DDINMF achieves the conventional DDI prediction (AUROC = 0.872 and AUPR = 0.605) and the comprehensive DDI prediction (AUROC = 0.796 and AUPR = 0.579). Compared with two state-of-the-art approaches, DDINMF shows it superiority. Finally, representing DDIs as a binary network and a signed network respectively, an analysis based on NMF reveals crucial knowledge hidden among DDIs. CONCLUSIONS: Our approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. More importantly, it reveals several key points about the DDI network: (1) both binary and signed networks show fairly clear clusters, in which both drug degree and the difference between positive degree and negative degree show significant distribution; (2) the drugs having large degrees tend to have a larger difference between positive degree and negative degree; (3) though the binary DDI network contains no information about enhancive and degressive DDIs at all, it implies some of their relationship in the comprehensive DDI matrix; (4) the occurrence of signs indicating enhancive and degressive DDIs is not random because the comprehensive DDI network is equipped with a structural balance. |
format | Online Article Text |
id | pubmed-5907306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59073062018-04-30 Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization Yu, Hui Mao, Kui-Tao Shi, Jian-Yu Huang, Hua Chen, Zhi Dong, Kai Yiu, Siu-Ming BMC Syst Biol Research BACKGROUND: Drug-drug interactions (DDIs) always cause unexpected and even adverse drug reactions. It is important to identify DDIs before drugs are used in the market. However, preclinical identification of DDIs requires much money and time. Computational approaches have exhibited their abilities to predict potential DDIs on a large scale by utilizing pre-market drug properties (e.g. chemical structure). Nevertheless, none of them can predict two comprehensive types of DDIs, including enhancive and degressive DDIs, which increases and decreases the behaviors of the interacting drugs respectively. There is a lack of systematic analysis on the structural relationship among known DDIs. Revealing such a relationship is very important, because it is able to help understand how DDIs occur. Both the prediction of comprehensive DDIs and the discovery of structural relationship among them play an important guidance when making a co-prescription. RESULTS: In this work, treating a set of comprehensive DDIs as a signed network, we design a novel model (DDINMF) for the prediction of enhancive and degressive DDIs based on semi-nonnegative matrix factorization. Inspiringly, DDINMF achieves the conventional DDI prediction (AUROC = 0.872 and AUPR = 0.605) and the comprehensive DDI prediction (AUROC = 0.796 and AUPR = 0.579). Compared with two state-of-the-art approaches, DDINMF shows it superiority. Finally, representing DDIs as a binary network and a signed network respectively, an analysis based on NMF reveals crucial knowledge hidden among DDIs. CONCLUSIONS: Our approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. More importantly, it reveals several key points about the DDI network: (1) both binary and signed networks show fairly clear clusters, in which both drug degree and the difference between positive degree and negative degree show significant distribution; (2) the drugs having large degrees tend to have a larger difference between positive degree and negative degree; (3) though the binary DDI network contains no information about enhancive and degressive DDIs at all, it implies some of their relationship in the comprehensive DDI matrix; (4) the occurrence of signs indicating enhancive and degressive DDIs is not random because the comprehensive DDI network is equipped with a structural balance. BioMed Central 2018-04-11 /pmc/articles/PMC5907306/ /pubmed/29671393 http://dx.doi.org/10.1186/s12918-018-0532-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yu, Hui Mao, Kui-Tao Shi, Jian-Yu Huang, Hua Chen, Zhi Dong, Kai Yiu, Siu-Ming Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title | Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title_full | Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title_fullStr | Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title_full_unstemmed | Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title_short | Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
title_sort | predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907306/ https://www.ncbi.nlm.nih.gov/pubmed/29671393 http://dx.doi.org/10.1186/s12918-018-0532-7 |
work_keys_str_mv | AT yuhui predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT maokuitao predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT shijianyu predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT huanghua predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT chenzhi predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT dongkai predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization AT yiusiuming predictingandunderstandingcomprehensivedrugdruginteractionsviaseminonnegativematrixfactorization |